Abstract
Methyl (±)-(5Z,12E,14E)-9α-acetoxy-16-(3-chlorophenoxy)-15-deoxy-11-oxo-17,18,19,20-tetranorprosta- 5,12,14-trienoate was synthesized via selective protection/deprotection of the hydroxy groups in cloprostenol methyl ester, followed by oxidation of the C11–OH group and DBU-promoted elimination of the 9-acetoxy group.
Similar content being viewed by others
References
Strauss, D.S. and Glass, C.K., Med. Res. Rev., 2001, vol. 21, p. 185.
Fukushima, S., Kishimoto, S., Takeuchi, Y., and Fukushima, M., Adv. Drug Delivery Rev., 2000, vol. 45, p. 65.
Rossi, A., Karahi, P., Natoli, G., Takahashi, T., Chen, Y., Karin, M., and Santoro, M.G., Nature, 2000, vol. 403, p. 103.
Pande, V. and Ramos, M., Bioorg. Med. Chem. Lett., 2005, vol. 15, p. 4057.
Suzuki, M., Mori, M., Niva, T., Hirata, R., Furuta, K., Ishikawa, T., and Noyori, R., J. Am. Chem. Soc., 1997, vol. 119, p. 2376.
Furuta, K., Tomokiyo, K., Satoh, T., Watanabe, Y., and Suzuki, M., ChemBioChem, 2000, vol. 1, p. 283.
Shibata, T., Kondo, M., Osawa, T., Shibata, N., Kobayashi, M., and Uchida, K., J. Biol. Chem., 2002, vol. 277, p. 10459.
Forman, B.M., Tontonoz, P., Chen, J., Brun, R.P., Spiegelman, B.M., and Evans, R.M., Cell, 1995, vol. 83, p. 803.
Fitzpatric, F.A. and Wynalda, M.A., J. Biol. Chem., 1983, vol. 258, p. 11713.
Kitade, M., Tanaka, H., De, S., Ivashima, M., Igushi, K., and Takahashi, T., Chem. Eur. J., 2006, vol. 12, p. 1368.
Tanaka, H., Hasegawa, T., Kita, N., Nakahara, H., Shibata, T., Oe, S., Ojika, M., Uchida, K., and Takahashi, T., Chem._Asian J., 2006, vol. 1, p. 669.
Fukushima, S., Takeuchi, Y., Kishimoto, S., Yamashita, S., Uetsuki, K., Shirakawa, S., Suzuki, M., Furuta, K., Nojori, R., Sasaki, H., Kikuchi, Y., Kita, T., Yamori, T., Sawada, J., Kojima, M., Hazato, A., Kurosumi, S., and Fukushima, M., Anti-Cancer Drugs, 2001, vol. 12, p. 221.
Zurawinski, R., Mikolajczyk, M., Cieslak, M., Krolewska, K., and Kazmierczak-Baranska, J., Org. Biomol. Chem., 2015, vol. 13, p. 7000.
Vostrikov, N.S., Lobko, I.F., and Miftakhov, M.S., Tetrahedron Lett., 2014, vol. 55, p. 5622.
Tolstikov, G.A., Miftakhov, M.S., Vostrikov, N.S., Kuznetsov, O.M., Singizova, V.Kh., Starostin, E.K., Adler, M.E., Valeev, F.A., and Danilova, N.A., USSR Inventor’s Certificate no. 1 512 065, 1988; Byull. Izobret., 1989, no.36.
Tolstikov, G.A., Miftakhov, M.S., Komisarova, N.G., Akbutina, F.A., Adler, M.E., Selezneva, N.K., Vel’der, Ya.L., Vostrikov, N.S., and Platonov, V.E., Zh. Org. Khim., 1992, vol. 28, p. 724.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © N.S. Vostrikov, I.F. Lobko, L.V. Spirikhin, M.S. Miftakhov, 2016, published in Zhurnal Organicheskoi Khimii, 2016, Vol. 52, No. 12, pp. 1774–1781.
Rights and permissions
About this article
Cite this article
Vostrikov, N.S., Lobko, I.F., Spirikhin, L.V. et al. Practical F/Δ12,14-D transformation in the prostaglandin series. synthesis of methyl (±)-(5Z,12E,14E)-9α-acetoxy- 16-(3-chlorophenoxy)-15-deoxy-11-oxo-17,18,19,20-tetranorprosta- 5,12,14-trienoate from cloprostenol. Russ J Org Chem 52, 1765–1772 (2016). https://doi.org/10.1134/S1070428016120095
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1070428016120095